Cromolyn Sodium Oral Solution (Concentrate)
Concentrate
Current Active — Day 923
High impact — Only one manufacturer supplies this drug; any disruption leaves no immediate alternative source.
FDA shortage record
- Substance
- Cromolyn Sodium Oral Solution (Concentrate)
- Manufacturers / suppliers
-
- Ritedose Pharmaceuticals, LLC
- Ailex Pharmaceuticals
- Dosage form
- Concentrate
- Presentation
- Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96)
- Route(s)
- ORAL
- Therapeutic category
- Pulmonary/Allergy
- Package NDC
76204-025-96- Initially posted
- 11/03/2023
- Days on shortage list
- 923
- Current FDA status
- Current
- Shortage entries (current dataset)
- 1 record for Cromolyn Sodium Oral Solution (Concentrate)
Reason and context
Reason reported: Other
No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or [email protected].
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
d208df15-c823-6e0d-e053-2a95a90ad1be). - FDA UNII identifier:
Q2WXR1I0PK. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.